Correction to “Discovery of Hydroxamic Acid Ester Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer”

Xingxing Cheng; Zheqi Hu; Huihuan Mao; Ziyue Li; Zhen Wang; Yixuan Tang; Shihui Huang; Yujing Huang; Chunxiang Yin; Hanxi Xing; Sijia Chen; Yuhan Jiang; Ting Hu; Jiawen Zuo; Wenxin Yan; Hongfeng Gu; Ping Wei; Yungen Xu; Qihua Zhu; Yi Zou

doi:10.1021/acs.jmedchem.6c00616

Correction to “Discovery of Hydroxamic Acid Ester Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer”

Journal of Medicinal Chemistry 2026 Open access

Read full text

Authors: Xingxing Cheng, Zheqi Hu, Huihuan Mao, Ziyue Li, Zhen Wang, Yixuan Tang, Shihui Huang, Yujing Huang, Chunxiang Yin, Hanxi Xing, Sijia Chen, Yuhan Jiang

+8 more

Ting Hu, Jiawen Zuo, Wenxin Yan, Hongfeng Gu, Ping Wei, Yungen Xu, Qihua Zhu, Yi Zou

DOI: 10.1021/acs.jmedchem.6c00616

Cited by: 1

Fields of Study & Subjects

Cancer-related gene regulation Nuclear Receptors and Signaling Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source: Journal of Medicinal Chemistry
Publisher: American Chemical Society (ACS)
Volume: 69
Issue: 6
Pages: 7491–7492
Publication date: 7 March 2026
Language: EN